All Work

Danielle Liverance

Kyverna Therapeutics Sinks 13%: Here’s Why

A single analyst note sent Kyverna Therapeutics tumbling despite a clinical milestone that had investors cheering just weeks ago, and the question now is whether the selloff marks a buying opportunity or the start…

Danielle Liverance · 2 months ago

Fermi America Sinks 11.5% with $375 Million Offering

A $375 million convertible note offering sent Fermi America into a sharp Friday selloff, but the real question hanging over the pre-revenue power developer is whether it can land a binding tenant before its…

Danielle Liverance · 2 months ago

Ionis Pharmaceuticals Drops Another 9% as Bad News Piles Up

A Phase 3 trial failure has erased a year of gains for Ionis Pharmaceuticals in just days, and the ripple effects are rattling rivals across the RNA and rare-disease biotech space with more catalysts…

Danielle Liverance · 2 months ago

Rackspace Technology (RXT) Rebounds 22% After Brutal Week

One brutal week and one chaotic Thursday left Rackspace investors staring at a guidance cut, a shareholder investigation, and a last-minute AI gamble with Palantir. Now the stock is bouncing hard, and the question…

Danielle Liverance · 2 months ago

An AI-Powered Flash Crash Is Coming. The Market Isn’t Ready.

G7 central banks are quietly war-gaming kill switches for AI trading systems, and regulators in three countries have already admitted the rulebook cannot contain what their own firms have deployed. The window to act…

Danielle Liverance · 2 months ago

5 Dividend Stocks Flashing Warning Signs

A fat dividend yield can be the last thing a struggling company offers before it disappears entirely. These five income stocks are paying out more than their earnings and cash flow can support, and…

Danielle Liverance · 2 months ago

4 Overlooked Dividend Stocks Yielding 4%+ to Buy in July

The S&P 500 barely yields 2%, yet four stocks hiding in plain sight across airlines, semiconductors, PCs, and consumer electronics are paying well above 4% with the cash flow to back it up. Most…

Danielle Liverance · 2 months ago

5 Solid Dividend Stocks to Buy in July

Yield above 4% sounds appealing until you realize most high-payout stocks are traps waiting to spring. These five names span life insurance, asset management, banking, and consumer staples, and each one earns its dividend…

Danielle Liverance · 2 months ago

5 Income Stocks Yielding 10%+ with Dividends in Danger

Massive dividend yields are a huge draw for investors – both because everyone likes income…and because a company that can pay a dividend surely has the cash to pay out that dividend, right? Most…

Danielle Liverance · 2 months ago

Jim Cramer: Buy the Dip on These 3 Stocks Now

A sharp sector rotation knocked down some of the market's steadiest names, and Jim Cramer told CNBC viewers this week that the resulting dislocations are exactly the kind of setup patient investors should welcome.…

Danielle Liverance · 2 months ago